Outlook Therapeutics, Inc. Common Stock OTLK

$0.89 -19.20% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K FORM 8-K 2026-08-14 View →
424B5 424B5 2026-08-14 View →
8-K FORM 8-K 2026-08-14 View →
424B5 424B5 2026-08-12 View →
8-K FORM 8-K 2026-08-12 View →
4 PRIMARY DOCUMENT 2026-07-29 View →
8-K FORM 8-K 2026-07-24 View →
8-K FORM 8-K 2026-07-24 View →
4 PRIMARY DOCUMENT 2026-07-23 View →
4 PRIMARY DOCUMENT 2026-07-23 View →
S-3 FORM S-3 2026-07-17 View →
8-K FORM 8-K 2026-07-16 View →
8-K FORM 8-K 2026-06-26 View →
8-K FORM 8-K 2026-06-16 View →
4 PRIMARY DOCUMENT 2026-06-03 View →
4 Insider transaction 2026-06-01 View →
DEF 14A DEF 14A 2026-06-01 View →
8-K FORM 8-K 2026-06-01 View →
8-K FORM 8-K 2026-05-29 View →
424B5 424B5 2026-05-29 View →
8-K FORM 8-K 2026-05-28 View →
4 PRIMARY DOCUMENT 2026-05-27 View →
4 PRIMARY DOCUMENT 2026-05-27 View →
4 PRIMARY DOCUMENT 2026-05-27 View →
4 PRIMARY DOCUMENT 2026-05-27 View →
8-K FORM 8-K 2026-05-26 View →
8-K FORM 8-K 2026-05-18 View →
10-Q 10-Q 2026-05-15 View →
424B5 424B5 2026-05-13 View →
8-K FORM 8-K 2026-05-13 View →
8-K FORM 8-K 2026-04-23 View →
424B5 424B5 2026-04-23 View →
8-K FORM 8-K 2026-04-21 View →
8-K FORM 8-K 2026-04-07 View →
8-K FORM 8-K 2026-03-25 View →
424B5 424B5 2026-03-25 View →
424B5 424B5 2026-03-23 View →
8-K FORM 8-K 2026-03-16 View →
8-K FORM 8-K 2026-03-11 View →
8-K FORM 8-K 2026-03-10 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.89
Market Cap
$205.70 million
52-Week Range
$0.16 $3.39
Average Volume
14.86 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.